Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Research and development spending
3Y CAGR
-16.5%/yr
vs +14.6%/yr prior
5Y CAGR
-6.8%/yr
Recent deceleration
Acceleration
-31.1pp
Decelerating
Percentile
P60
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
4 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.63M | -5.8% |
| 2025 | $9.16M | -23.1% |
| 2024 | $11.91M | -19.7% |
| 2023 | $14.82M | -16.1% |
| 2022 | $17.66M | +44.2% |
| 2021 | $12.24M | +38.9% |
| 2020 | $8.81M | +2.5% |
| 2019 | $8.60M | +31.0% |
| 2018 | $6.56M | +123.5% |
| 2017 | $2.94M | - |